Quantcast

ARMSTRONG TEASDALE LLP: Armstrong Teasdale Adds IP Partner Dhruv Kaushal in Boston

LEGAL NEWSLINE

Saturday, November 23, 2024

ARMSTRONG TEASDALE LLP: Armstrong Teasdale Adds IP Partner Dhruv Kaushal in Boston

Hs

Armstrong Teasdale LLP issued the following announcement on Apr. 21.

Armstrong Teasdale announces the addition of Partner Dhruv Kaushal, Ph.D. to the firm’s Intellectual Property practice in Boston. He brings more than a decade of experience serving as strategic counsel to life sciences clients in patent matters and technology transactions, and joins a robust team of IP practitioners firmwide. To date in 2021, Armstrong Teasdale has added more than 50 attorneys.

Drawing on a diverse background in private practice and as a research scientist, in-house legal counsel and a member of the founding team of a cell therapy startup, Kaushal helps clients understand and manage the full scope of intellectual property-driven implications for their businesses.

Clients ranging from small biotech startups to Fortune 500 companies look to Kaushal as a thought partner in protecting innovations, managing third-party intellectual property risk and facilitating transactions involving intellectual property assets. His practice encompasses patent preparation and prosecution, patent portfolio management, analyses of patent scope and validity, patent landscapes and white space, new product clearance and preparation of formal opinions of counsel on invalidity or noninfringement, negotiation and drafting of licenses and other IP-focused commercial agreements, providing IP support for M&A and financing transactions, and post-grant patent proceedings before the USPTO.

As a former in-house patent attorney, Kaushal is experienced in tailoring legal services to address specific business challenges and in translating legal work product into actionable information for stakeholders at all levels of client organizations. He leverages his operating experience to help clients execute on their IP strategies through services including patent portfolio audits and patent quality assessments, IP activity roadmaps for R&D enterprises, and implementing and owning client-side processes for management of patent assets and third-party patent risk. Kaushal’s scientific background includes doctoral work in neurosciences at the University of California San Diego and a postdoctoral fellowship in molecular immunology at Children’s Hospital Boston and Harvard Medical School.

Original source can be found here.

More News